From biopharma and therapeutics to life sciences and robotics—and much, much more—the Penn Center for Innovation touches it all. The Center, created in 2014, thrives by being the University’s one-stop-shop for commercialization and entrepreneurship.
This past year has been one for the books. The Center this week presented its fiscal 2018 “Year in Review,” showcasing its achievements in commercial activities. Penn Today took a dive into some of the report’s most significant numbers.
359
Penn faculty members submitted inventions for review
801
patents filed
679
commercial agreements executed
$69.4 million
in licensing income
$109.8 million
in revenue received from industry-sponsored research agreements
Understanding order to disorder at the atomic scale opens possibilities for next-generation electronic devices
A Penn team has developed insight into the chemical and geometric mechanisms underlying the synthesis of new 2D materials, paving the way for next-gen devices, biomedical applications, and cleaner, quicker energy conversion and storage.
Exposure to air pollution worsens Alzheimer’s disease
New research from Penn Medicine finds living in areas with high concentration of air pollution is associated with increased buildup of amyloid and tau proteins in the brains of Alzheimer’s patients, accelerating cognitive decline.
Penn buildings achieve LEED certifications, showcasing commitment to sustainability
Three recent building projects at the University of Pennsylvania have earned LEED Platinum, Gold, and Silver certifications, underscoring Penn’s ongoing commitment to sustainable design and construction.
What stiffening lung tissue reveals about the earliest stages of fibrosis
A Penn Engineering team has targeted the lung’s extracellular matrix to better understand early fibrosis by triggering the formation of special chemical bonds that increase tissue stiffness in specific locations, mimicking the first physical changes that may lead to lung fibrosis.
